Current treatment options for nhl patients refractory to standard therapy: Recent data in single-agent and combination therapy

Clinical Advances in Hematology and Oncology

Volumn 8, Issue 5, 2010, Pages 1-

  Kahl, Brad S ^a   Cheson, Bruce D ^b   Friedberg, Jonathan W ^c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; BORTEZOMIB; CLOFARABINE; INOTUZUMAB OZOGAMICIN; LENALIDOMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CAL 101; MONOCLONAL ANTIBODY GA 101; MONOCLONAL ANTIBODY PRO 131921; OFATUMUMAB; RITUXIMAB; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CANCER RELAPSE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; DRUG SAFETY; HUMAN; LONG TERM CARE; MEDICAL RESEARCH; NONHODGKIN LYMPHOMA; TREATMENT RESPONSE;

EID: 77953664155     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)